Vault-13

WUXI BIOLOGICS CAYMAN INC USD00000083 144A REG S WXIBF

COM · Common Stock · CUSIP G97008117

1 institutional holders +0 vs Q4 2020
9,236,8699.2m shares reported held*
$115.7mreported value*
0 new 1 added 0 reduced 0 sold out net bought ≈ $1.4m (+107.9k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $12.52.

Trends to Q1 2021

Institutional holders

Managers reporting a position, each quarter

001Q4 20: 1Q1 21: 11Q4 20Q1 21
Numbers
QuarterHolders
Q4 20201
Q1 20211

Biggest buyers

GILDER GAGNON HOWE & CO LLC Added +107,902+107.9k

Biggest sellers

None

Holders, Q1 2021

#ManagerLocationShares Value% of their portfolioChangeShares change
1 GILDER GAGNON HOWE & CO LLC 0.62% of their portfolio New York, NY 9,236,8699.2m $115.7m $115.7m 0.62% Added +107.9k +107,902